BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 1099119)

  • 1. Functional role of antibody against "core" glycolipid of Enterobacteriaceae.
    Young LS; Stevens P; Ingram J
    J Clin Invest; 1975 Oct; 56(4):850-61. PubMed ID: 1099119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-protective immunity to Gram-negative bacilli: studies with core glycolipid of Salmonella minnesota and antigens of Streptococcus pneumoniae.
    Young LS; Stevens P
    J Infect Dis; 1977 Aug; 136 Suppl():S174-80. PubMed ID: 19538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific and Nonspecific immunity to Serratia marcescens infection.
    Simberkoff MS; Moldover NH; Rahal JJ
    J Infect Dis; 1976 Oct; 134(4):348-53. PubMed ID: 789788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards serodiagnosis of Serratia marcescens infections: examination of sera from noninfected patients and from experimentally infected rabbits for anti-H and anti-O antibodies; S. marcescens O-antigen cross-reactions with those of other enterobacteriaceae.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):490-6. PubMed ID: 7036590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal and opsonic activities of normal sheep serum against gram-negative bacteria.
    Mittal KR; Ingram DG
    Am J Vet Res; 1975 Aug; 36(08):1189-93. PubMed ID: 1098532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aerosol immunization with RE 595 Salmonella minnesota on lung bactericidal activity against Serratia marcescens, Enterobacter cloacae, and Pseudomonas aeruginosa.
    LaForce FM
    Am Rev Respir Dis; 1977 Aug; 116(2):241-9. PubMed ID: 407823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria.
    McCabe WR; Bruins SC; Craven DE; Johns M
    J Infect Dis; 1977 Aug; 136 Suppl():S161-6. PubMed ID: 330775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precipitating antibody against core glycolipid of Enterobacteriaceae.
    Young LS; Stevens PR
    Experientia; 1974 Feb; 30(2):192-3. PubMed ID: 4205369
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the opsonic capacity of core lipopolysaccharide antiserum of equine origin against smooth Escherichia coli 0111:B4, using macrophage chemiluminescence.
    Morris DD; Harmon BG; Moore JN
    Am J Vet Res; 1989 Aug; 50(8):1272-8. PubMed ID: 2675693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiserum treatment of gram-negative bacteremia.
    Braude AI; Ziegler EJ; McCutchan JA
    Schweiz Med Wochenschr; 1978 Dec; 108(48):1872-6. PubMed ID: 362528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-endotoxin core glycolipid antibody: the preparation of immune serum of E. Coli J5].
    Xu XN; Li ZJ; Li YP
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jun; 16(6):358-60. PubMed ID: 15182450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsonization of serum-sensitive and serum-resistant Escherichia coli by rough mutant (Re) antisera.
    Crowley JP; Zinner SH; Peter G
    J Lab Clin Med; 1982 Feb; 99(2):197-205. PubMed ID: 7038008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive protection against heterologous gram-negative bacteria mediated by antiserum to epimeraseless Rc mutant of Salmonella minnesota.
    Konstantinov G; Karacholeva M; Eskenazy M; Ivanova R; Vassileva J; Naumova F; Tekelieva R; Strahilov D
    Ann Immunol (Paris); 1982; 133D(1):71-6. PubMed ID: 6760795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escherichia coli antibodies in opsonisation and protection against infection.
    van Dijk WC; Verbrugh HA; van Erne-van der Tol ME; Peters R; Verhoef J
    J Med Microbiol; 1981 Nov; 14(4):381-9. PubMed ID: 7031250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential use of shared antigens for immunization against gram-negative bacillary infections.
    McCabe WR; DeMaria A; Johns M
    Prog Clin Biol Res; 1980; 47():107-17. PubMed ID: 6163155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive protection of NMRI mice against Serratia marcescens: comparative efficacy of commercial human IgG immunoglobulin preparations and rabbit anti-O, -H, -K, -life cell and -protease immune sera.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 254(4):480-8. PubMed ID: 6202079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Core" glycolipid of enterobacteriaceae: immunofluorescent detection of antigen and antibody.
    Young LS; Hoffman KR; Stevens P
    Proc Soc Exp Biol Med; 1975 Jun; 149(2):389-96. PubMed ID: 807915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-protection against Salmonella enteritidis infection in mice.
    Padmanaban VD; Mittal KR
    Acta Microbiol Acad Sci Hung; 1979; 26(4):283-91. PubMed ID: 397732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms.
    Opal SM; Palardy JE; Chen WH; Parejo NA; Bhattacharjee AK; Cross AS
    J Infect Dis; 2005 Dec; 192(12):2074-80. PubMed ID: 16288370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An oral enteritis-vaccine composed of twelve heat-inactivated Enterobacteriaceae 3. Communication: studies on efficacy tests in mice protection tests (author's transl)].
    Raettig H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):511-20. PubMed ID: 7036591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.